Earnings

Take-Two Interactive has closed its books on fiscal year 2026, with investor focus now squarely fixed on the horizon. The...

Biopharmaceutical firm Ocugen is transitioning from clinical development to the regulatory phase, with its lead gene therapy candidate approaching a...

In a rare admission, legendary investor Warren Buffett conceded to a significant error in judgment regarding his stake in Apple...

The advertising technology firm The Trade Desk is experiencing a significant shift in its shareholder base. Despite posting solid operational...

T1 Energy unveiled a substantial set of announcements today, combining quarterly results, a shift in its board leadership, and a...

All eyes are on Tilray Brands this Wednesday as the company prepares to release its third-quarter 2026 financial results. The...

Market experts are growing more optimistic about Cardiff Oncology's financial trajectory. Following the biotechnology firm's stronger-than-anticipated performance in February, analysts...

SolarEdge Technologies finds itself navigating a challenging path back to profitability, with its latest financial results highlighting the significant headwinds...

The stock of cybersecurity firm Rubrik has been testing its lowest levels in a year, following a challenging period for...

Despite announcing record annual revenues and a substantial order backlog, shares in the Czechoslovak Group (CSG) have been under significant...